Covington Capital Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Covington Capital Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3K	Hold	100	–	–	﹤0.01%	990
2022 Q2	$3K	Hold	100	–	–	﹤0.01%	957
2022 Q1	$3K	Hold	100	–	–	﹤0.01%	1007
2021 Q4	$4K	Hold	100	–	–	﹤0.01%	890
2021 Q3	$5K	Hold	100	–	–	﹤0.01%	890
2021 Q2	$5K	Hold	100	–	–	﹤0.01%	845
2021 Q1	$5K	Hold	100	–	–	﹤0.01%	745
2020 Q4	$5K	Buy	+100	New	+$4.32K	﹤0.01%	717

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Covington Capital Management's IDNA Position: Q3 2022 in Review

Covington Capital Management held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q3 2022 at 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Covington Capital Management first reported a position in IDNA in Q4 2020 and has held it in 8 quarters since. The position peaked at $5K in Q3 2021. 67 funds tracked by Wall St. Rank hold IDNA as of Q3 2022.

Covington Capital Management held 100 shares of iShares Genomics Immunology and Healthcare ETF worth $3K as of Q3 2022.
Covington Capital Management left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q3 2022.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #990 holding.
Covington Capital Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and has held it in 8 quarters since.
Covington Capital Management's iShares Genomics Immunology and Healthcare ETF position peaked at $5K in Q3 2021.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.